Boston Business JournalCambridge startup Jounce to get $225m in Celgene dealThe Boston GlobeJounce Therapeutics Inc., a three-year-old Cambridge startup, has struck a collaboration deal with an upfront payment of $225 million to jointly develop cancer drugs with Celgene Corp. The agreement, potentially worth as much as $2.3 billion, will help ...Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development PactTheStreet.comCelgene (CELG), Jounce Therapeutics Enter Immuno-oncology Development CollaborationStreetInsider.com​Cambridge's Jounce announces hefty $2.5B deal with Celgene for cancer drugsBoston Business Journal (blog)MarketWatch -Financial Timesall 10 news articles »

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News